Skip to main content
. Author manuscript; available in PMC: 2013 Jan 1.
Published in final edited form as: Neuropharmacology. 2011 Sep 2;62(1):35–41. doi: 10.1016/j.neuropharm.2011.08.044

Figure 3.

Figure 3

Targets for induction of synaptogenesis and ketamine-like effects. Potential targets that could produce ketamine like effects include presynaptic mGlu2/3 receptor antagonists and postsynaptic positive AMPA receptor potentiating agents. Both would lead to increased glutamate transmission and AMPA receptor activation, and thereby stimulate mTOR signaling and increase synaptogenesis. See text for details.